ICYMI: New study confirms policies like H.R. 3 could significantly reduce drug development

Anew study from economists at the University of Chicago examined the impact that government price-setting policies for medicines, like those in H.R. 3, could have if implemented. The economists found that a policy like H.R. 3 could reduce investment in the research and development (R&D) of new medicines by up to 60% between 2021 and 2039. The results reinforce why so manyAmericans have raised concerns over price-setting policies.

Source: The Catalyst - October 18, 2021 Category: Pharmaceuticals Authors: Gabby Migliara Tags: Drug Cost Part D Medicare Part B Proactive Agenda Source Type: news